Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Amortizatization of Intangibles (2022 - 2025)

Rani Therapeutics Holdings (RANI) has 4 years of Amortizatization of Intangibles data on record, last reported at -$797000.0 in Q3 2025.

  • For Q3 2025, Amortizatization of Intangibles fell 193.22% year-over-year to -$797000.0; the TTM value through Sep 2025 reached $73000.0, down 95.94%, while the annual FY2024 figure was $1.2 million, 46.16% down from the prior year.
  • Amortizatization of Intangibles reached -$797000.0 in Q3 2025 per RANI's latest filing, down from $805000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $855000.0 in Q3 2024 and bottomed at -$797000.0 in Q3 2025.
  • Average Amortizatization of Intangibles over 4 years is $304800.0, with a median of $378000.0 recorded in 2024.
  • The widest YoY moves for Amortizatization of Intangibles: up 713.13% in 2025, down 193.22% in 2025.
  • A 4-year view of Amortizatization of Intangibles shows it stood at $641000.0 in 2022, then dropped by 27.46% to $465000.0 in 2023, then crashed by 118.28% to -$85000.0 in 2024, then crashed by 837.65% to -$797000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Amortizatization of Intangibles were -$797000.0 in Q3 2025, $805000.0 in Q2 2025, and $150000.0 in Q1 2025.